Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Mol Neurobiol. 2018 Nov 3;56(7):4786–4798. doi: 10.1007/s12035-018-1416-y

Figure 5. Performance evaluation of the 8-lncRNA based risk score.

Figure 5.

A) Receiver operating characteristic curve for 5-year survival shows UVA8 has better Area-Under-Curve compared with other predictors. B) Area-Under-Curve plotted for different durations of survival for 8-lncRNA based risk score, tumor grade, Age, IDH mutation status and gender of patients in TCGA cohort. C) Cox multivariate regression with clinical information and risk score calculated from UVA8 for survival in TCGA cohort. D) Concordance-index showing measure of concordance of predictor with survival of patients in TCGA.